Age Standardized Incidence Rate-ASR GLOBOCAN ASR ASR.

Transkript

1 p [ ] Age Standardized Incidence Rate-ASR ASR - ASR - GLOBOCAN C B - Amiralmasi@arakmu.ac.ir

2 - p< ICD-O C22 Cochran-Armitage WinPepi 2.1 CI ± ± ± ± ± ± ± ± ±

3

4 References 1. Etemadi A, Sadjadi A, Semnani SH, et al. Cancer Registry in Iran: A brief overview. Arch Iran Med 2008, 11(5): Alsayyad J, Hamadeh R. Cancer incidence among the Bahraini population: A five-year ( ) experience. Ann Saudi Med 2007; 27(4): Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN Int J Cancer 2010, 127(12): Mousavi SM, Gouya MM, Ramazani R, et al. Cancer incidence and mortality in Iran. Ann Oncol 2009; 20(3): Cabanes A, Vidal E, Aragones N, et al. Cancer mortality trends in Spain: Ann Oncol 2010; 21(Suppl 3): iii14-iii Bosch FX, Ribes J, Diaz M and Cleries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004; 127(5 Suppl 1): S5-S Lin NF, Tang J, Ismael HS. Study on environmental etiology of high incidence areas of liver cancer in China. World J Gastroenterol 2000; 6(4): Kirk GD, Bah E, Montesano R. Molecular epidemiology of human liver cancer: Insights into etiology, pathogenesis and prevention from The Gambia, West Africa. Carcinogenesis 2006; 27(10): Hall AJ, Wild CP. Liver cancer in low and middle income countries. BMJ 2003; 326(7397): Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 2010; 42(Suppl 3): S206-S Boffetta P, Hashibe M, La Vecchia C, et al. The burden of cancer attributable to alcohol drinking. Int J Cancer 2006; 119(4): Saunders JB, Latt N. Epidemiology of alcoholic liver disease. Bailliere's Clin Gastroenterol 1993; 7(3): Babaei M, Mousavi S, Malek M, et al. Cancer occurrence in Semnan province, Iran: Results of a population-based cancer registry. Asian Pac J Cancer Prev 2005; 6(2): El Mistiri M, Verdecchia A, Rashid I, et al. Cancer incidence in eastern Libya: The first report from the Benghazi Cancer Registry, Int J Cancer 2007; 120(2): Sadjadi A, Malekzadeh R, Derakhshan MH, et al. Cancer occurrence in Ardabil: Results of a populationbased Cancer Registry from Iran. Int J Cancer 2003; 107(1):

5 Epidemiology of liver and intrahepatic bile ducts Cancer based on Fars Province Cancer Registry s Data, ( ) Mahin Farahmand, 1 Amir Almasi-Hashiani, 2 Mohammad Hossein Fallahzade 3 Background: Liver cancer is the fifth most frequent cancer in men and the seventh in women. The aim of this study was to determine the liver and bile ducts cancers epidemiology in Fars province, during 2001 to Materials and Method: In this epidemiological study incidence rates were calculated per 100,000 people a year and age standardized incidence rate (ASR) performed by direct method using the world standard population. Results: Out of 344 liver cancer cases, 54.4 and 45.6 percent were in male and female, respectively. ASR was estimated as 3.4 per 100,000 people a year in 2008 and liver cancer incidence rate in Fars province has a significantly increasing trend (p=0.001). Conclusion: The ASR of liver cancer in this study showed that this province as same as other countries of western Asia has low incidence rate. Keywords: liver cancer, Standardized Incidence Rate, Crude Incidence Rate 1. Social medicine specialists, Health deputy, Shiraz University of medical sciences, Shiraz, Iran 2. Department of Epidemiology, Faculty of Health, Arak University of Medical Sciences, Arak, Iran 3. Department of pediatrics, School of medicine, Shiraz University of medical sciences, Shiraz, Iran